Subscribe to RSS
DOI: 10.1055/s-2008-1067091
Synthesis and Antiviral Activities of Novel Purinyl- and Pyrimidinylcarbanucleosides Derived from Indan [1]
Publication History
Publication Date:
16 May 2008 (online)

Abstract
Starting from (±)-trans- and (±)-cis-3-hydroxymethyl-1-indanol, novel 6-substituted purinylcarbanucleoside derivatives of indan were synthesised through a key coupling reaction with 6-chloropurine under Mitsunobu conditions. Suzuki-Miyaura reactions of the protected 6-chloropurine derivative with different arylboronic acids afforded the corresponding 6-arylpurinylcarbanucleoside derivatives. Finally, three new 5-halouracilcarbanucleosides were prepared by the reaction of a uracilcarbanucleoside with different N-halosuccinimides. All of the new analogues were evaluated for antiviral activity against a wide variety of viruses.
Key words
synthesis - indan carbanucleosides - Mitsunobu reaction - Suzuki-Miyaura reaction - antiviral activity
Part of this work was presented at the XIV Congreso Nacional of The Sociedad Española de Química Terapéutica, Bilbao: Spain, September 2005.
- For recent reviews on carbanucleosides, see:
-
2a
Rodríguez JB.Comin MJ. Mini-Rev. Med. Chem. 2003, 3: 95 -
2b
Ichikawa E.Kato K. Curr. Top. Med. Chem. 2001, 8: 385 -
2c
Zhu X.-F. Nucleosides, Nucleotides Nucleic Acids 2000, 19: 651 -
2d
Ferrero M.Gotor V. Chem. Rev. 2000, 100: 4319 -
2e
Agrofoglio L.Challand SR. Acyclic, Carbocyclic and l -Nucleosides Kluwer Academic; Dordrecht: 1998. -
3a
Roberts S.Biggadike K.Borthwick AD.Kirk B. Topics in Medicinal ChemistryLeeming PR. Royal Society of Chemistry; London: 1988. -
3b
Marquez VE.Lim M. Med. Res. Rev. 1986, 6: 1 -
3c
Saunders J.Cameron JM. Med. Res. Rev. 1995, 15: 497 -
4a
Vince R.Hua M.Brownell J.Daluge S.Lee F.Shannon WM.Lavelle GC.Qualls J.Weislow OS.Kiser R.Canonico PG.Schultz RH.Narayanan VL.Mayo JG.Shoemaker RH.Boyd MR. Biochem. Biophys. Res. Commun. 1988, 156: 1046 -
4b
Vince R.Hua M. J. Med. Chem. 1990, 33: 17 -
4c
Vince R,Peterson ML,Lackey JW,Mook RA, andPartridge JJ. inventors; PCT Int. Appl. WO 9115490. ; Chem. Abstr. 1992, 116, 59910 -
5a
Daluge SM.Good SS.Faleto MB.Miller WH.St. Clair MH.Boone LR.Tisdale M.Parry NR.Reardon JE.Dornsife RE.Averett DR.Krenitsky TA. Antimicrob. Agents Chemother. 1997, 41: 1082 -
5b
Crimmins MT.King BW. J. Org. Chem. 1996, 61: 4192 -
5c
Foster RH.Faulds D. Drugs 1998, 55: 729 -
6a
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.De Clercq E. Synthesis 2002, 1084 -
6b
Yao S.-W.López VHC.Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.Cordeiro MNDS. Bioorg. Med. Chem. 2003, 11: 4999 -
7a
Fernández F.García-Mera X.Morales M.Vilariño L.Caamaño O.De Clercq E. Tetrahedron 2004, 60: 9245 -
7b
Fernández F.García-Mera X.López C.Morales M.Rodríguez-Borges JE. Synthesis 2005, 3549 - 8
Thomas S.McDowall JE.Cheah V.Bye A.Segal MB. The Entry of Abacavir into the Guinea-Pig Brain: Comparison with other Reverse Transcriptase Inhibitors 12th World AIDS Conference; Geneva: 1998. -
9a
Cheson BD. Hematol. Cell. Ther. 1996, 38 (Suppl. 2): 109 -
9b
Bergmann L. Leukemia 1997, 11 (Suppl. 2): 29 -
9c
Hocek M.Hol A.Votruba I.Dvoráková H. J. Med. Chem. 2000, 43: 1817 - 10
Grunewald GL.Sall DJ.Monn JA. J. Med. Chem. 1988, 31: 433 - 11
Fernández F.García-Mera X.Rodríguez-Borges JE. Tetrahedron: Asymmetry 2001, 12: 365 -
12a
Mitsunobu O. Synthesis 1981, 1 -
12b
Hughes DL. Org. React. 1992, 42: 335 -
12c
Lawrence S. PharmaChem 2002, 1: 12 -
12d
But TYS.Toy PH. Chem. Asian J. 2007, 2: 1340 -
13a
Hocek M. Eur. J. Org. Chem. 2003, 245 -
13b
Havelková M.Dvorák D.Hocek M. Synthesis 2001, 1704 -
13c
Havelková M.Hocek M.Cesnek M.Dvorák D. Synlett 1999, 1145 -
14a
Hocek M. Eur. J. Org. Chem. 2003, 245 -
14b
Hocek H.Hockova D.Stambasky J. Collect. Czech. Chem. Commun. 2003, 68: 837 -
14c
Hocek H.Holy A.Votruba I.Dvorakova H. J. Med. Chem. 2000, 43: 1817 -
14d
Havelková M.Hocek M.Cesnek M.Dvorák D. Synlett 1999, 1145 - 15
Corey EJ.Venkateswarlu A. J. Am. Chem. Soc. 1972, 94: 6190 - 16
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE. Synthesis 2001, 239 -
17a
Sako M.Saito T.Kameyama K.Hirota K.Maki Y. Synthesis 1987, 829 -
17b
Srivastavam PC.Nagpal KL. Experientia 1970, 26: 220 - 18
De Clercq E. In Vivo and Ex Vivo Text Systems to Rationalize Drug Design and DeliveryCromelin D.Couvreur P.Duchene D. Editions de Santé; Paris: 1994.
References
Part of this work was presented at the XIV Congreso Nacional of The Sociedad Española de Química Terapéutica, Bilbao: Spain, September 2005.